These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mg/Al-LDH as a nano-adjuvant for pertussis vaccine: a evaluation compared with aluminum hydroxide adjuvant. Li D; Xu M; Li G; Zheng Y; Zhang Y; Xia D; Wang S; Chen Y Nanotechnology; 2022 Mar; 33(23):. PubMed ID: 35189608 [No Abstract] [Full Text] [Related]
5. The potential of adjuvants to improve immune responses against TdaP vaccines: A preclinical evaluation of MF59 and monophosphoryl lipid A. Agnolon V; Bruno C; Leuzzi R; Galletti B; D'Oro U; Pizza M; Seubert A; O'Hagan DT; Baudner BC Int J Pharm; 2015 Aug; 492(1-2):169-76. PubMed ID: 26149936 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants. Berthold I; Pombo ML; Wagner L; Arciniega JL Vaccine; 2005 Mar; 23(16):1993-9. PubMed ID: 15734073 [TBL] [Abstract][Full Text] [Related]
7. Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation. Auderset F; Ballester M; Mastelic-Gavillet B; Fontannaz P; Chabaud-Riou M; Reveneau N; Garinot M; Mistretta N; Liu Y; Lambert PH; Ochs M; Siegrist CA Front Immunol; 2019; 10():1520. PubMed ID: 31333656 [TBL] [Abstract][Full Text] [Related]
8. Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity. Ausar SF; Zhu S; Duprez J; Cohen M; Bertrand T; Steier V; Wilson DJ; Li S; Sheung A; Brookes RH; Pedyczak A; Rak A; Andrew James D Commun Biol; 2020 Aug; 3(1):427. PubMed ID: 32759959 [TBL] [Abstract][Full Text] [Related]
9. Silicon or Calcium Doping Coordinates the Immunostimulatory Effects of Aluminum Oxyhydroxide Nanoadjuvants in Prophylactic Vaccines. Li M; Yao Z; Wang H; Ma Y; Yang W; Guo Y; Yu G; Shi W; Zhang N; Xu M; Li X; Zhao J; Zhang Y; Xue C; Sun B ACS Nano; 2024 Jul; 18(26):16878-16894. PubMed ID: 38899978 [TBL] [Abstract][Full Text] [Related]
10. Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles. Sun B; Ji Z; Liao YP; Wang M; Wang X; Dong J; Chang CH; Li R; Zhang H; Nel AE; Xia T ACS Nano; 2013 Dec; 7(12):10834-49. PubMed ID: 24261790 [TBL] [Abstract][Full Text] [Related]
11. Crystalline and Amorphous Preparation of Aluminum Hydroxide Nanoparticles Enhances Protective Antigen Domain 4 Specific Immunogenicity and Provides Protection Against Anthrax. Gogoi H; Mani R; Aggarwal S; Malik A; Munde M; Bhatnagar R Int J Nanomedicine; 2020; 15():239-252. PubMed ID: 32021177 [TBL] [Abstract][Full Text] [Related]
12. Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatis. Visan L; Sanchez V; Kania M; de Montfort A; de la Maza LM; Ausar SF Hum Vaccin Immunother; 2016 Sep; 12(9):2341-50. PubMed ID: 27104338 [TBL] [Abstract][Full Text] [Related]
13. Aluminum (oxy) Hydroxide Nanorods Activate an Early Immune Response in Pseudomonas aeruginosa Vaccine. Chen Y; Yang F; Yang J; Hou Y; He L; Hu H; Lv F ACS Appl Mater Interfaces; 2018 Dec; 10(50):43533-43542. PubMed ID: 30480997 [TBL] [Abstract][Full Text] [Related]
14. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens. Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718 [TBL] [Abstract][Full Text] [Related]
15. Genetically detoxified pertussis toxin induces superior antigen specific CD4 T cell responses compared to chemically detoxified pertussis toxin. Surendran N; Pichichero M Hum Vaccin Immunother; 2019; 15(5):1167-1170. PubMed ID: 30689515 [TBL] [Abstract][Full Text] [Related]
16. Advances in aluminum hydroxide-based adjuvant research and its mechanism. He P; Zou Y; Hu Z Hum Vaccin Immunother; 2015; 11(2):477-88. PubMed ID: 25692535 [TBL] [Abstract][Full Text] [Related]
17. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Morefield GL; Sokolovska A; Jiang D; HogenEsch H; Robinson JP; Hem SL Vaccine; 2005 Feb; 23(13):1588-95. PubMed ID: 15694511 [TBL] [Abstract][Full Text] [Related]
18. Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines. Seubert A; D'Oro U; Scarselli M; Pizza M Expert Rev Vaccines; 2014 Oct; 13(10):1191-204. PubMed ID: 25183193 [TBL] [Abstract][Full Text] [Related]
19. Multiplex immunoassay for in vitro characterization of acellular pertussis antigens in combination vaccines. Agnolon V; Bruno C; Galletti B; Mori E; Ugozzoli M; Pergola C; O'Hagan DT; Baudner BC Vaccine; 2016 Feb; 34(8):1040-6. PubMed ID: 26784684 [TBL] [Abstract][Full Text] [Related]
20. The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism. Ulanova M; Tarkowski A; Hahn-Zoric M; Hanson LA Infect Immun; 2001 Feb; 69(2):1151-9. PubMed ID: 11160013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]